|Articles|June 1, 2022
SEC-MALS Method for Characterizing mRNA v3
Author(s)Wyatt
SEC-MALS quantifies biophysical attributes of mRNA, including molar mass, percent aggregates, Rg and Rh, and how they are affected by formulation and storage conditions.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FDA Clears In-Vivo Gene Editing Therapy PBGENE-DMD for Duchenne Trial
2
The Clinical Execution Gap: Why Great Science Often Fails at the Trial Stage
3
VectorY Doses First Patient in TDP-43–Targeting ALS Trial
4
Women in STEM: Building Sustainable Cost and Access Models for Advanced Therapies (Part 1)
5